Dr. Joseph L Jackson Sr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Jones Ave, Waynesboro, GA 30830 Phone: 706-554-5147 Fax: 706-554-6111 |
Dr. Joseph L Jackson Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Jones Ave, Waynesboro, GA 30830 Phone: 706-554-5147 Fax: 706-554-6111 |
Bonnie P Jenkins, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Dogwood Dr, Waynesboro, GA 30830 Phone: 706-437-0046 Fax: 706-437-0546 |
Dr. Johnny F Christian, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Jones Ave, Waynesboro, GA 30830 Phone: 706-554-5147 Fax: 706-554-6111 |
News Archive
Measuring the levels of a natural body chemical may allow doctors to reduce the duration of antibiotic use and improve the health outcomes of critically ill patients.
In a recent bioRxiv paper, scientists from Institut Pasteur and other research centers in France demonstrated how pathological effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are modulated by cellular proteins that can either inhibit or facilitate cell fusion and subsequent syncytia formation.
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
New research reveals that depressive symptoms, stress, anxiety, and anger and lack of social support in patients with rheumatoid arthritis (RA) were linked to atherosclerosis-a build-up of fatty deposits in the arteries that contributes to cardiovascular disease. The study published in Arthritis Care & Research, a journal of the American College of Rheumatology, suggests that screening and treatment of psychosocial symptoms may curb the cardiovascular disease burden in RA patients.
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with a nine-week course of adjuvant trastuzumab compared to those treated for one year, according to a subgroup analysis of the Short-HER trial reported at ESMO 2018 Congress in Munich.
› Verified 8 days ago